Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Navidea Biopharmaceuticals Announces First 110 Subjects Imaged In NAV3-35 Normative Database Phase 2b Study To Support Rheumatoid Arthritis Indications


Benzinga | Jul 19, 2021 07:31AM EDT

Navidea Biopharmaceuticals Announces First 110 Subjects Imaged In NAV3-35 Normative Database Phase 2b Study To Support Rheumatoid Arthritis Indications






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC